The neuromodulator adenosine mediates dark-adaptive changes in retinal photoreceptors through A 2a receptors. In cold-blooded vertebrates, opsin mRNA expression is lower at night than during the day. In the present study, we tested whether adenosine could inhibit opsin mRNA expression in cultured rod cells and if endogenous adenosine acts to suppress opsin mRNA in the intact retina at night. Semi-quantitative in situ hybridization showed that treatment with 100 nM of the A 2a /A 2b agonist N 6 -[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine (DPMA) reduced opsin mRNA 41% in cultured rod cells. The effect of DPMA was blocked by 10 lM of the A 2a antagonist 8-(3-chlorostyryl)caffeine (CSC) but not by 10 lM of the A 2b antagonist alloxazine. One micromolar adenosine alone had no effect on opsin mRNA.However, in the presence of the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA), 1 lM adenosine reduced opsin mRNA 61%. EHNA alone reduced opsin mRNA by 26%. Consistent with an A 2a receptor mechanism, 100 nM forskolin (adenylate cyclase agonist) decreased opsin mRNA 34%. Finally, northern blots showed that intravitreal injection of 10 lM CSC at night increased opsin I mRNA 38%. Thus, endogenous adenosine suppresses rod opsin I mRNA expression at night; in vitro results indicate this reduction occurs through A 2a -like receptor binding and stimulation of adenylate cyclase activity. Keywords: A 2a receptor, adenosine, mRNA expression, opsin, retina, rod photoreceptor. The rod visual pigment, rhodopsin, is composed of the chromophore 11-cis-retinal and the integral membrane glycoprotein opsin. Absorption of light by rhodopsin initiates vision through a G-protein linked signal transduction cascade which ultimately inhibits neurotransmitter release. While the importance of opsin to rod cell function has been well established, its importance to rod cell survival has only recently been uncovered. Studies using transgenic and knockout mice have shown that single point mutations in the opsin gene as well as overexpression or deletion of normal opsin can result in rod cell death and retinal degenerative disease (Dryja et al. 1991;Olsson et al. 1992;Li et al. 1996;Humphries et al. 1997;Lem et al. 1999). Therefore, understanding the mechanisms that regulate opsin gene expression is critical to our knowledge of rod cell biology and to the development of strategies for treating retinal disease.Previous reports have provided details of the rod opsin promoter and have demonstrated its activation by the transacting factors Nrl and Crx (Ahmad 1995;Chen and Zack 1996;Rehemtulla et al. 1996;Chen et al. 1997). Other studies have shown that rod opsin mRNA exhibits rhythmic Abbreviations used: AP, alkaline phosphatase; BCIP, 5-bromo-4-chloro-3-indolyl phosphate; CSC, 8-(3-chlorostyryl)caffeine; DABCO, 1,4-diazabicyclo[2.2.2]octane; DMSO, dimethylsulfoxide; DPMA, N 6 -[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine; EHNA, erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride...